300685 Stock Overview
Develops and sells molecular diagnostics for oncology precision medicine in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Amoy Diagnostics Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥18.80 |
| 52 Week High | CN¥26.90 |
| 52 Week Low | CN¥14.60 |
| Beta | 0.63 |
| 1 Month Change | -11.61% |
| 3 Month Change | -6.14% |
| 1 Year Change | -28.95% |
| 3 Year Change | -62.18% |
| 5 Year Change | -3.86% |
| Change since IPO | 357.76% |
Recent News & Updates
Earnings Report: Amoy Diagnostics Co., Ltd. Missed Revenue Estimates By 6.1%
Apr 24
Amoy Diagnostics (SZSE:300685) Could Easily Take On More Debt
Apr 18Recent updates
Earnings Report: Amoy Diagnostics Co., Ltd. Missed Revenue Estimates By 6.1%
Apr 24Amoy Diagnostics (SZSE:300685) Could Easily Take On More Debt
Apr 18What Amoy Diagnostics Co., Ltd.'s (SZSE:300685) 33% Share Price Gain Is Not Telling You
Mar 02Is Amoy Diagnostics Co., Ltd. (SZSE:300685) Worth CN¥22.0 Based On Its Intrinsic Value?
Mar 01Shareholder Returns
| 300685 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | -5.1% | -1.3% | 1.3% |
| 1Y | -28.9% | -18.2% | -9.1% |
Return vs Industry: 300685 underperformed the CN Biotechs industry which returned -18.2% over the past year.
Return vs Market: 300685 underperformed the CN Market which returned -9.1% over the past year.
Price Volatility
| 300685 volatility | |
|---|---|
| 300685 Average Weekly Movement | 5.6% |
| Biotechs Industry Average Movement | 6.5% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in CN Market | 10.6% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 300685's share price has been volatile over the past 3 months.
Volatility Over Time: 300685's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 1,119 | Jiemin Luo | www.amoydx.com |
Amoy Diagnostics Co., Ltd. develops and sells molecular diagnostics for oncology precision medicine in China and internationally. The company offers NGS, real-time PCR, FISH, and extraction assays. Amoy Diagnostics Co., Ltd.
Amoy Diagnostics Co., Ltd. Fundamentals Summary
| 300685 fundamental statistics | |
|---|---|
| Market cap | CN¥7.64b |
| Earnings (TTM) | CN¥268.37m |
| Revenue (TTM) | CN¥1.08b |
27.6x
P/E Ratio6.9x
P/S RatioIs 300685 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300685 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.08b |
| Cost of Revenue | CN¥181.70m |
| Gross Profit | CN¥899.93m |
| Other Expenses | CN¥631.56m |
| Earnings | CN¥268.37m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.68 |
| Gross Margin | 83.20% |
| Net Profit Margin | 24.81% |
| Debt/Equity Ratio | 3.0% |
How did 300685 perform over the long term?
See historical performance and comparison